We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
RELX
RELX
$62B
| $35.5M | 0.08% |
1,699,026
+996,191
| +142% | +$21.5M |
|
227
Avery Dennison
AVY
$13.4B
| $35.2M | 0.08% |
331,532
+170,835
| +106% | +$19.8M |
|
|
AAN.A
228
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $35M | 0.08% |
751,883
-139,576
| -16% | -$6.5M |
|
|
JOBS
229
DELISTED
51job Inc
JOBS
| $34.7M | 0.08% |
403,591
-53,601
| -12% | -$3.87M |
|
230
ON Semiconductor
ON
$31.6B
| $34.5M | 0.08% |
1,409,017
-8,183
| -0.6% | -$197K |
|
231
Dick's Sporting Goods
DKS
$18.7B
| $34.5M | 0.08% |
982,959
-1,486,387
| -60% | -$48.5M |
|
|
RDS.A
232
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $33.8M | 0.08% |
+530,400
| New | +$34.9M |
|
|
NEWR
233
DELISTED
New Relic, Inc.
NEWR
| $33.8M | 0.08% |
455,962
+445,262
| +4,161% | +$29.8M |
|
234
Labcorp
LH
$25.9B
| $33.7M | 0.08% |
242,345
+130,135
| +116% | +$19.1M |
|
235
Amdocs
DOX
$6.22B
| $33.7M | 0.08% |
504,561
+178,810
| +55% | +$12M |
|
236
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $33.4M | 0.08% |
126,764
+16,555
| +15% | +$4.52M |
|
237
TriNet
TNET
$3.14B
| $33.3M | 0.08% |
719,497
-13,900
| -2% | -$614K |
|
|
VEDL
238
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $33.3M | 0.08% |
1,893,393
+1,369,061
| +261% | +$27.6M |
|
239
Insperity
NSP
$2.01B
| $33.2M | 0.08% |
477,010
| – | – |
|
|
SNBR
240
DELISTED
Sleep Number
SNBR
| $33M | 0.08% |
937,967
+244,221
| +35% | +$8.94M |
|
|
PTR
241
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $32.6M | 0.07% |
467,897
-68,667
| -13% | -$4.96M |
|
|
COHR
242
DELISTED
Coherent Inc
COHR
| $32.5M | 0.07% |
173,389
-18,111
| -9% | -$4.37M |
|
|
VMW
243
DELISTED
VMware, Inc
VMW
| $32.4M | 0.07% |
267,013
-272,211
| -50% | -$34.3M |
|
244
Broadridge
BR
$19B
| $32.3M | 0.07% |
294,835
+271,591
| +1,168% | +$27M |
|
245
Ross Stores
ROST
$81.9B
| $32.2M | 0.07% |
+413,057
| New | +$32.8M |
|
|
FBR
246
DELISTED
Fibria Celulose Sa
FBR
| $32.1M | 0.07% |
1,643,973
-1,579,028
| -49% | -$28.1M |
|
247
Procter & Gamble
PG
$339B
| $31.2M | 0.07% |
394,100
+155,700
| +65% | +$13M |
|
248
Banco Macro
BMA
$5.35B
| $30.7M | 0.07% |
284,124
+85,600
| +43% | +$9.29M |
|
249
MarketAxess Holdings
MKTX
$5.72B
| $30.2M | 0.07% |
138,788
-47,394
| -25% | -$9.75M |
|
250
iShare MSCI Eurozone ETF
EZU
$9.91B
| $30.1M | 0.07% |
694,772
+689,772
| +13,795% | +$30.7M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.